Cefepime for prophylaxis of infections in the surgery of cholelithiasis. Results of a multicentric comparative trial.
暂无分享,去创建一个
P. Del Rio | G. Nuzzo | M. Sianesi | M. Vellone | R. Mazzitelli | P. Fragapane | C. Allegri | Marcello di Millo
[1] Jerome J. Schentag,et al. Once‐Daily Cefepime Versus Ceftriaxone for Nursing Home–Acquired Pneumonia , 2007, Journal of the American Geriatrics Society.
[2] P. Gentileschi,et al. Antibiotic prophylaxis in elective laparoscopic cholecystectomy: lack of need or lack of evidence? , 2004, Surgical Endoscopy And Other Interventional Techniques.
[3] M. Schaller,et al. Cefepime versus Imipenem-Cilastatin for Treatment of Nosocomial Pneumonia in Intensive Care Unit Patients: a Multicenter, Evaluator-Blind, Prospective, Randomized Study , 2003, Antimicrobial Agents and Chemotherapy.
[4] L. Wise,et al. Mini-Laparotorny Cholecystectomy in the Era of Laparoscopic Cholecystectomy: A Community-Based Hospital Perspective , 2003, The American surgeon.
[5] W. Schwesinger,et al. Laparoscopic cholecystectomy for elderly patients: gold standard for golden years? , 2003, Archives of surgery.
[6] D. Figgitt,et al. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections. , 2002, Drugs.
[7] E. Targarona,et al. Laparoscopic surgery and surgical infection , 2000, The British journal of surgery.
[8] W. P. Ledet,et al. Minicholecystectomy: a safe, cost-effective day surgery procedure. , 1999, Archives of surgery.
[9] P. Biron,et al. Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer). , 1998, The Journal of antimicrobial chemotherapy.
[10] H. Lippert,et al. Antimicrobial Prophylaxis in Laparoscopic and Conventional Cholecystectomy , 1998, Chemotherapy.
[11] M. Zervos,et al. Cefepime versus Ceftriaxone for Empiric Treatment of Hospitalized Patients with Community-Acquired Pneumonia , 1998, Antimicrobial Agents and Chemotherapy.
[12] P. Biron. Cefepime versus imipenem-cilastin as empirical monotherapy in 400 febrile patients with short duration neutropenia , 1998 .
[13] H. Lippert,et al. Antimicrobial prophylaxis in laparoscopic and conventional cholecystectomy . Conclusions of a large prospective multicenter quality assurance study in Germany. , 1998, Chemotherapy.
[14] R. Davis,et al. Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections. , 1994, PharmacoEconomics.
[15] E. Croce,et al. Laparocholecystectomy. 6,865 cases from Italian institutions. , 1994, Surgical endoscopy.
[16] H. Bryson,et al. A REVIEW OF THIS ANTIBACTERIAL ACTIVITY, PHARMACOKINETICS PROPERTIES AND THERAPEUTIC USE , 1994 .
[17] P. Heseltine,et al. A randomized study of cefepime versus the combination of gentamicin and meziocillin as an adjunct to surgical treatment in patients with acute cholecystitis , 1994, Surgery, gynecology & obstetrics.
[18] A. Ehrhardt,et al. β-Lactam resistance amongst Enterobacter species , 1993 .
[19] C. Grassi,et al. Cefepime: overview of activity in vitro and in vivo. , 1993, The Journal of antimicrobial chemotherapy.
[20] A. Ehrhardt,et al. beta-Lactam resistance amongst Enterobacter species. , 1993, The Journal of antimicrobial chemotherapy.
[21] S. Wilson,et al. Cefepime for infections of the biliary tract. , 1993, Surgery, gynecology & obstetrics.
[22] C. Sanders. beta-Lactamases of gram-negative bacteria: new challenges for new drugs. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] W J Martone,et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.
[24] R. Hancock,et al. Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae , 1991, Antimicrobial Agents and Chemotherapy.
[25] P. Schmitz,et al. Meta‐analysis of randomized, controlled clinical trials of antibiotic prophylaxis in biliary tract surgery , 1990, The British journal of surgery.
[26] R. N. Brogden,et al. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. , 1988, Drugs.
[27] H. Neu,et al. β-Lactam Antibiotics: Structural Relationships Affecting in Vitro Activity and Pharmacologic Properties , 1986 .
[28] C. Sanders,et al. Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications. , 1985, The Journal of infectious diseases.
[29] Price Ke,et al. Basic design of beta-lactam antibiotics--cephalosporins. , 1984 .
[30] K. E. Price,et al. Basic design of beta-lactam antibiotics--cephalosporins. , 1984, Scandinavian Journal of Infectious Diseases. Supplementum.
[31] M. Sianesi,et al. [Peroperative antibiotic therapy in biliary surgical diseases]. , 1982, Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma.